Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

442 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Few Major Developments In Drugs And Pharmaceutical Industry

    No NOC for Pharmaceutical Exports to Developed Countries: The Central Drugs Standard Control Organisation (CDSCO) has relaxed the drug regulatory clearance for the pharmaceutical exporters of India.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Sun Pharma – Ranbaxy: A Panacea For Ranbaxy's Ills?

    April 6, 2014 was a red letter day for the Indian pharmaceutical industry as Sun Pharmaceutical Industries Limited ("Sun Pharma") and Ranbaxy Laboratories Limited ("Ranbaxy") announced that they had entered into definitive documents for merger of Ranbaxy with Sun Pharma ("Transaction").
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nishith Desai Associates
Nishith Desai Associates
  • Article

    Indian Patent Office (IPO) Publishes The Revised Guidelines In The Field Of Pharmaceuticals

    The Indian Patent office published their revised guidelines for examine the patent application in the field of Pharmaceuticals.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    CCI To Investigate Monsanto Mahyco Monsanto Biotech (I) Limited & Ors.

    The CCI directed the Director General to investigate Mahyco Monsanto Biotech (I) Limited, Monsanto Holdings Private Ltd., Monsanto Inc., U.S.A. and Maharashtra Hybrid Seeds Company Ltd.
    IndiaAntitrust/Competition Law
    Vaish Associates Advocates
    Vaish Associates Advocates
  • Article

    CDSCO Issues Comprehensive SEC Guidance Document For Consistent Regulatory Evaluation

    To strengthen the technical evaluation process that supports regulatory decisions and to bring formal structure to the functioning of Subject Expert Committees (SECs)...
    IndiaFood, Drugs, Healthcare, Life Sciences
    LexCounsel
    LexCounsel
  • Article

    Food & Pharma Flash - June 2014

    The Health Ministry initiated consultation on government action plan for the first 100 days with respect to healthcare reforms.
    IndiaFood, Drugs, Healthcare, Life Sciences
    PSA
    PSA
  • Article

    Health Ministry Issues Grouping Guidelines For Medical Device Applications

    The applicant may group medical devices having same or similar intended uses or commonality of technology and submitted in a single application.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Restriction On Importation Of Refurbished Medical Devices Into India

    In an important development, importation of used/ refurbished medical devices into India have been restricted by Central Drugs Standard Control Organisation (CDSCO).
    IndiaFood, Drugs, Healthcare, Life Sciences
    Acuity Law
    Acuity Law
  • Article

    Challenges In Patenting Pharmaceutical Products In India

    This article looks into the challenges faced in the patenting of therapeutic antibodies in India.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Patents – Making Available Fungicide For Use In High-temperature Regions Is ‘enhancement In Efficacy’ Under Section 3(d)

    The Delhi High Court has ruled on a significant patent law question regarding whether making a fungicide stable at high temperatures constitutes an enhancement in efficacy under Section 3(d) of the Patents Act, 1970.
    IndiaIntellectual Property
    Lakshmikumaran & Sridharan
    Lakshmikumaran & Sridharan
  • Article

    Food & Pharma - Flash

    This edition of Flash apprises you with the major developments in the food and pharmaceutical sector this month.
    IndiaFood, Drugs, Healthcare, Life Sciences
    PSA
    PSA
  • Article

    CCI Unconditionally Approves Temasek’s Acquisition Of A 14.56% Stake In Romsons

    Temasek Holdings' subsidiary Jongsong Investments acquired a 14.56% stake in Indian medical device manufacturer Romsons Group through a combination of preference share subscription and purchase from the Khanna family. The Competition Commission of India examined horizontal overlaps in medical devices and personal care products, along with twelve vertical and three complementary relationships involving Temasek portfolio companies, ultimately approving the transaction despite multiple market linkages.
    IndiaAntitrust/Competition Law
    AZB & Partners
    AZB & Partners
  • Article

    Delhi HC Quashes Ban On Wockhardt's Anti-Inflammatory Drug

    The Delhi High Court, on January 01, 2019, set aside the Central Government's ban on Wockhardt's anti-inflammatory medicine ‘Ace Proxyvon', a Fixed Dose combination of Aceclofenac 100 mg, Paracetamol 325 mg ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    EY On Budget 2025: Key Amendments Proposed In Union Budget 2025 For Pharma And Life Science Sector

    The Hon'ble Finance Minister presented the Union Budget 2025 on 01 February 2025 in the Lok Sabha.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Ernst & Young
    Ernst & Young
  • Article

    Premas Biotech And Oravax Enter Into Licensing Deal For Commercialization Of VLP Injectable Vaccine Technology In India

    Recently, Oravax Medical Inc., ("Oravax" has entered into a licensing agreement with Premas Biotech to make available for commercialization of Oravax's virus-like particle (VLP) vaccine technology.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Production Linked Incentives - Boost For Manufacturing In Healthcare Sector

    The Pharmaceutical and Medtech sectors have been growing at double digit rates with the potential to continue to grow at similar rates over the next decade.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    DelSiTech And Visus Therapeutics Enter Into Patent Licensing Arrangement

    Recently, DelSiTech Ltd. ("DelSiTech"), a Finland based drug delivery company entered into a patent licensing agreement over DelSiTech's patents with Visus Therapeutics ("Visius"), a US based company.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Medicines Patent Pool's Voluntary Licensing; Unique In Its Efforts To Better Treat The Infection

    Efforts of Medicines Patent Pool (hereinafter referred to as "MPP"); a United Nations backed public health organisation, founded in July 2010, and based in Geneva, Switzerland are praiseworthy.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Need For A Central Database System Of Trademarks

    A need for a centralized database system of trademarks of licensed drugs is being felt by the Drug Controller General of India to check the menace of drugs with similar names in the market.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Premas Biotech And Oravax Enter Into Licensing Deal For Commercialisation Of VLP Injectable Vaccine Technology In India

    Recently, Oravax Medical Inc., ("Oravax" has entered into a licensing agreement with Premas Biotech to make available for commercialisation Oravax's virus-like particle (VLP) vaccine technology.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Showing 21–40 of 442 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics